To determine the prevalence of Acinetobacter spp. from different clinical specimens and detect different types of β-lactamase enzymes.
INTRODUCTION
Gram-negative bacteria cause different infections, which are becoming increasingly prevalent and constitute a serious threat to public health worldwide. Systemic infections from these organisms are diffi cult to treat and carry unacceptably high mortality, as high as 50% because of lack of effi cacious treatment regimens (Kaye and Pogue 2015) .
Genus Acinetobacter comprises more than 50 validly named species. The most signifi cant among them is A. baumannii (Kolk et al. 2019 ) that commonly infects immuno-compromised patients (Park et al. 2017) . They are ubiquitous organisms and prevail in natural environments (Kolk et al. 2019) . They also represent the normal fl ora in humans (Almasaudi 2016) .
Acinetobacter have emerged as one of the most troublesome classes of pathogen in health careassociated infections (Silveira et al. 2019) . They cause various infections like hospital-acquired pneumonia, community-acquired pneumonia, bacteremia, trauma and wound infection, urinary tract infection, meningitis and other manifestations like endocarditis, peritonitis, opthalmitis or keratitis associated with contact lens use following eye surgery (Almasaudi 2016) .
Acinetobacter species are well suited for genetic exchange and have the remarkable capacity for acquisition of foreign genetic material, which helps in obtaining resistance to the antibiotics (Kolk et al. 2019) . AbaR1 resistance cluster, which is an 86-kb region, have been identifi ed in Acinetobacter spp. that contains 45 resistance genes in MDR isolates (Perez et al. 2007 ).
Bacterial resistance against β-lactam antibiotics is now becoming threat in the interventions of antibiotics due to the production of β-lactamase enzymes. Khanal et al. (2013) reported the prevalence of ESBL, MBL and AmpC β-lactamase producing Acinetobacter to be 9.09%, 10.90% and 46.80% respectively. In another study conducted by Bhandari et al. (2015) , 12.5% ESBL, 63.8% MBL and 31.37% AmpC β-lactamase producing Acinetobacter were reported. OXA-51 of A. baumannii is involved in cephalosporin resistance (AmpC) (Gordon and Wareham 2009).
The spread of multi drug resistant Acinetobacter infection has been increasing and is creating a problem in the treatment. The early detection of MDR isolates and their ability to produce β-lactamase enzyme is necessary to neutralize the serious threat. So this study was conducted with the objective to identify different Acinetobacter species and to detect various types of β-lactamases (ESBL, MBL and AmpC β-lactamase) produced by it that could be helpful for the treatment and analysis of resistance mechanism of this bacterium and to search the alternative therapeutic options.
MATERIALS AND METHODS

Sample size and study population
The study was conducted in Paropakar Maternity and 
Ethical issues
The informed consent was taken from adult females. In case of neonates, the informed consent was taken from their guardians. Permission to conduct the study was obtained from the participating hospital.
Isolation and identifi cation of Acinetobacter species
The specimens were directly inoculated on Blood agar and MacConkey agar plates and incubated at 37°C for 24 hours. The species of Acinetobacter was identifi ed phenotypically in the laboratory by series of biochemical tests (Table 1) (Gupta et al. 2015) . 
Antibiotic susceptibility testing
The antibiotic susceptibility tests were performed 
Criterion for multidrug resistance
The defi ning criterion for an isolate to be multidrug resistant (MDR) was set as resistance to three or more drugs belonging to different structural classes (Magiorakos et al. 2012) .
Tests for ESBL
The ESBL production in bacterial isolates was screened by using Cefotaxime disc (30μg) (2018).
Tests for MBL
The screening test for the MBL production was performed by using Imipenem disc (10μg). If the zone of inhibition was less than or equal to 18 mm for Imipenem, the isolate was considered as potential MBL producer as stated by CLSI (2018). The screened isolates were further confi rmed by combined disc method using Imipenem (10 μg) alone and in combination with EDTA.
After overnight incubation at 37ºC, if the increase in inhibition zone with Imipenem-EDTA disc was greater than or equal to 7 mm than the Imipenem (10 μg) alone, it was interpreted as MBL producer as stated by Anwar et al. (2016) and Sujatha and Goyal (2017) .
Tests for AmpC β-lactamase
AmpC-lactamase production was screened by using Cefoxitin (30 μg) disc. If the zone of inhibition was less than or equal to 14 mm for Cefoxitin, the isolate was 
RESULTS
Out of 10,265 clinical specimens, 807 (7.86%) were found to be culture positive and the occurrence of
Acinetobacter was found to be 125 (15.48%). 113 (23.01%)
of Acinetobacter species were isolated from in-patients and 12 (3.78%) from out-patients (Table 2) . Amidst the Acinetobacter isolates, 65 (52%) were obtained from neonates' blood whereas only 1 (0.8%) was obtained from ear swab (Figure 1 ). TUJM VOL. 6, NO. 1, 2019 Out of 125 Acinetobacter spp., the most predominant species was Acinetobacter calcoaceticus-baumannii (Acb complex) (80%) followed by A. lowffi i (10.4%) ( Figure   2 ).
Figure 1: Distribution of Acinetobacter spp. in clinical specimens
Figure 2: Distribution of various species of Acinetobacter
Amongst total 125 Acinetobacter spp., 67 (53.6%) of the isolates were resistant towards Cefotaxime and 55 (44%) towards Piperacillin while all the isolates were sensitive towards Colistin followed by Tetracycline (85.6%) (Table 3) . Of the total Acinetobacter spp. 56 (44.8%) were MDR, 32 (57.14%) were ESBL producer, 18 (32.14%) were MBL producer and 2 (3.57%) were AmpC β-lactamase producer. The ESBL production and MBL production in MDR isolates were found to be statistically signifi cant while the AmpC β-lactamase production in MDR isolates was found to be statistically insignifi cant (Table   4 ). (Table 5) .
DISCUSSION
Acinetobacter species are ubiquitous organisms and prevail in natural environments (Kolk et al. 2019) . They also represent the normal fl ora in humans (Almasaudi 2016 which helps in obtaining resistance to the antibiotics (Kolk et al. 2019 ).
The incidence of Acinetobacter spp. from in-patients was found to be 90.4%, which is in accordance with previous studies carried out by Gupta et al. (2015) and Joshi et al. (2017) . The incidence of Acinetobacter infection was highest in in-patients and highest number of bacteria was isolated from neonates' blood as also stated by Gupta et al. (2015) . It is because Acinetobacter spp. is low virulence organism responsible for opportunistic infections in immuno-compromised patients, which increases the incidence of nosocomial infections. One of the reasons for the increased nosocomial infections by Acinetobacter spp. might be their endurance in dry conditions for long period of time and survival in a hospital environment and on the surface of healthcare worker hands (Park et al. 2017 ). The immune system of neonates is immature when they are born and it takes time to fully develop this immunity and thus they are easily attacked by various bacterial pathogens (Park et al. 2017 ).
The predominantly isolated species was Acinetobacter calcoaceticus baumanii (Acb complex) as also reported by Raina et al. (2015) and Gupta et al. (2015) . Almost half of the isolates were multi-drug resistant which is consistent with previous reports by Pathak et al. (2017) and Shrestha et al. (2015) . 
